Another network pharmacology study highlighted quercetin as a thyroid cancer treatment, with high binding affinity to modulators including MMP-1, C-X-C motif chemokine ligand-8, MMP-3, and collagen type 1 ꭤ1 [58]. The gene discussed is MMP3; the disease is thyroid cancer.